Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
This study is ongoing, but not recruiting participants.
Study NCT00066469
Information provided by National Cancer Institute (NCI)
First Received: August 6, 2003
Last Updated: April 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
